Haemodynamic effects of glucagon during acute myocardial infarction with left ventricular failure in man.
D000208:Acute Disease; D000368:Aged; D001786:Blood Glucose / Q000032:analysis; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D002306:Cardiac Volume / Q000187:drug effects; D005260:Female; D005934:Glucagon / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D006333:Heart Failure / Q000150:complications / Q000188:drug therapy*; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy*; D009325:Nausea / Q000139:chemically induced; D011188:Potassium / Q000097:blood; D011652:Pulmonary Circulation / Q000187:drug effects; D014655:Vascular Resistance / Q000187:drug effects; D014839:Vomiting / Q000139:chemically induced
D001786:Blood Glucose; D005934:Glucagon; D011188:Potassium